These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 7438179)
41. Denaturation of type II collagen in articular cartilage in experimental murine arthritis. Evidence for collagen degradation in both reversible and irreversible cartilage damage. Stoop R; van der Kraan PM; Buma P; Hollander AP; Poole AR; van den Berg WB J Pathol; 1999 Jul; 188(3):329-37. PubMed ID: 10419604 [TBL] [Abstract][Full Text] [Related]
42. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538 [TBL] [Abstract][Full Text] [Related]
43. [Bone-cartilage structures of the normal and pathologically changed femur head]. Stofft E; Richter IE; Belzer W Verh Anat Ges; 1977; (71 Pt 2):1419-26. PubMed ID: 610165 [No Abstract] [Full Text] [Related]
44. Presence and distribution of collagen II, collagen I, fibronectin, and tenascin in rabbit normal and osteoarthritic cartilage. Pfander D; Rahmanzadeh R; Scheller EE J Rheumatol; 1999 Feb; 26(2):386-94. PubMed ID: 9972974 [TBL] [Abstract][Full Text] [Related]
45. [Changes in the mucopolysaccharide content of the matrix of articular cartilage]. Castaldi D; De Amicis A; Toussoun M Chir Organi Mov; 1975; 62(6):605-15. PubMed ID: 131024 [No Abstract] [Full Text] [Related]
46. Telopeptides as markers of bone turnover in rheumatoid arthritis and osteoarthritis. Wong PK; Young L; Vaile JH; Tan L; Bertouch JV; Bleasel JF; White C Intern Med J; 2004; 34(9-10):539-44. PubMed ID: 15482266 [TBL] [Abstract][Full Text] [Related]
47. Proinflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteoarthritis. Lisignoli G; Toneguzzi S; Pozzi C; Piacentini A; Riccio M; Ferruzzi A; Gualtieri G; Facchini A J Rheumatol; 1999 Apr; 26(4):791-9. PubMed ID: 10229398 [TBL] [Abstract][Full Text] [Related]
48. [Activity of plasminogen activators and plasmin inhibitors in the joint capsule in various articular diseases (author's transl)]. Blasini C; Glas K; Blasini R; Haas S; Wriedt-Lübbe I; Blümel G Z Orthop Ihre Grenzgeb; 1981 Oct; 119(5):455-62. PubMed ID: 7198342 [TBL] [Abstract][Full Text] [Related]
49. Method of histomorphometric assessment of glycosaminoglycans in articular cartilage. Shimizu C; Coutts RD; Healey RM; Kubo T; Hirasawa Y; Amiel D J Orthop Res; 1997 Sep; 15(5):670-4. PubMed ID: 9420595 [TBL] [Abstract][Full Text] [Related]
50. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285 [TBL] [Abstract][Full Text] [Related]
52. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage. Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010 [TBL] [Abstract][Full Text] [Related]
53. [The biochemistry of articular cartilage in osteoarthritis]. Seppälä PO; Näntö V Duodecim; 1974; 90(16):1107-15. PubMed ID: 4277945 [No Abstract] [Full Text] [Related]
54. Biochemical and metabolic abnormalities in osteoarthritic human cartilage. Mankin HJ Fed Proc; 1973 Apr; 32(4):1478-80. PubMed ID: 4121832 [No Abstract] [Full Text] [Related]
55. Regional assessment of articular cartilage gene expression and small proteoglycan metabolism in an animal model of osteoarthritis. Young AA; Smith MM; Smith SM; Cake MA; Ghosh P; Read RA; Melrose J; Sonnabend DH; Roughley PJ; Little CB Arthritis Res Ther; 2005; 7(4):R852-61. PubMed ID: 15987487 [TBL] [Abstract][Full Text] [Related]
56. Biochemical and metabolic aspects of osteoarthritis. Mankin HJ Orthop Clin North Am; 1971 Mar; 2(1):19-31. PubMed ID: 4940528 [No Abstract] [Full Text] [Related]
57. The possible role of c-fos expression in rheumatoid cartilage destruction. Tsuji M; Hirakawa K; Kato A; Fujii K J Rheumatol; 2000 Jul; 27(7):1606-21. PubMed ID: 10914841 [TBL] [Abstract][Full Text] [Related]
58. Differential expression of IL-1 and TNF receptors in inflammatory arthritis and osteoarthritis. Ruggeri R; Pulsatelli L; Melchiorri C; Da Re R; Focherini MC; Veronesi M; Facchini A Boll Soc Ital Biol Sper; 1996; 72(1-2):15-20. PubMed ID: 8868110 [TBL] [Abstract][Full Text] [Related]
59. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis. Squires GR; Okouneff S; Ionescu M; Poole AR Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899 [TBL] [Abstract][Full Text] [Related]
60. Upregulation of type X collagen expression in osteoarthritic cartilage. von der Mark K; Frischholz S; Aigner T; Beier F; Belke J; Erdmann S; Burkhardt H Acta Orthop Scand Suppl; 1995 Oct; 266():125-9. PubMed ID: 8553841 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]